Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002669-23Phase 3Completed
Phase 3 trial of amoxicillin + clavulanate in surgical site infection (SSI) and bacterial wound infection (2 arms), sponsored by Hospital General Universitari de Granollers. Primary endpoint: Presence of surgical infection within 30 days after surgery. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002669-23.